Skip to content

Ketamine decreases HPA axis reactivity to a novel stressor in male but not female mice

Colin J. Johnston, Paul J. Fitzgerald, Jena S. Gewarges, Brendon O. Watson, Joanna L. Spencer-Segal

bioRxiv Preprint Server June 29, 2021 preprint DOI: 10.1101/2021.06.29.450387 via bioRxiv

Summary

AI-generated from the abstract

Ketamine, an antidepressant, interacts with the HPA axis, but its behavioral effects' dependence on this axis is unknown. In male and female mice subjected to chronic unpredictable stress, ketamine (30 mg/kg) or vehicle was given with or without metyrapone to block corticosterone production. No significant drug effects on behavior were observed. Males had higher fecal corticosterone levels and stress-induced increases than females. Ketamine lowered the corticosterone response to a novel stressor only in males. Corticosterone levels correlated with immobility in a behavioral test across all mice, suggesting shared neural circuitry for endocrine and behavioral responses that may be ketamine-responsive only in males.

Study at a glance

Characteristics Experimental study
Population Male and female C57BL/6J mice
Interventions Ketamine Metyrapone
Dose 30 mg/kg, i.p. (ketamine); 20 mg/kg, i.p. (metyrapone)
Duration One and two days after injection for behavioral tests
Topics Ketamine
Keywords Antidepressant Drug Medication Sex differences
Citations 5
Key finding Ketamine after chronic stress decreases the corticosterone response to a novel stressor in male mice but not in females.

Abstract

Ketamine is an antidepressant drug that interacts with the hypothalamic-pituitary-adrenal (HPA) axis, but whether this interaction is important for its behavioral effect is unknown. The goal of this experiment was to determine whether the behavioral response to ketamine depends on intact HPA axis function. Male and female C57BL/6J mice underwent chronic unpredictable stress prior to ketamine (30 mg/kg, i.p.) or vehicle treatment, with or without the glucocorticoid synthesis inhibitor metyrapone (20 mg/kg, i.p.) to block adrenal corticosterone production. Mice were tested in the forced swim test (FST) and open field test one and two days after injection, respectively. Fecal corticosterone was measured at select time points. No significant drug effects on behavior were observed. Males consistently had higher fecal corticosterone levels and stress-induced increases than females. Ketamine lowered the fecal corticosterone response to the FST only in males. These data show that ketamine after chronic stress decreases the corticosterone response to a novel stressor (the FST) in males, but not females. Corticosterone levels in all mice correlated with immobility in the FST, suggesting that shared neural circuitry could mediate both endocrine and behavioral responses. This circuitry may be ketamine-responsive only in males.

Explore topics

Comments

No comments yet.

Log in to comment